Acute Leukemia Updates

  • DCI APP lecture series is a once monthly 1 CME credit hour events directed toward advanced practice providers as well as pharmacists and registered nurses who care for all patients treated at Duke Cancer Institute.

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacists

Learning Objectives

  • Applying updated diagnostic criteria, genomic risk stratification, measurable residual disease assessment to guide management of acute myeloid leukemia and acute lymphoblastic leukemia
  • Selecting guideline-concordant frontline and relapsed or refactory treatment strategies based on patient fitness, disease biology and evolving 2025 to 2026 recommendations 
  • Incorporating recently approved and emerging therapies, including targeted agents, bispecific antibodies, and cellular therapies, into clinical practice.
  • Interpreting key clinical trial data and late breaking abstracts to inform evidence-based treatment decisions and identify areas of ongoing uncertainty. 

Course summary

Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
06/16/2026
Registration Expires: 
06/15/2028
Part of: 
DCI-Advanced Practice Provider Lecture Series 2026 Enduring
Rating: 
0
  • Sanghee Hong, MD
  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance
  • JA Credit - AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.